BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10228452)

  • 21. Modulation of striatal dopamine release by glycine transport inhibitors.
    Javitt DC; Hashim A; Sershen H
    Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted indole-2-carboxylates as potent antagonists of the glycine binding site associated with the NMDA receptor.
    Micheli F; Di Fabio R; Baraldi D; Conti N; Cugola A; Gastaldi P; Giacobbe S; Marchioro C; Mugnaini M; Rossi L; Pecunioso A; Pentassuglia G
    Arch Pharm (Weinheim); 1999 Aug; 332(8):271-8. PubMed ID: 10489537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonist.
    Baron BM; Cregge RJ; Farr RA; Friedrich D; Gross RS; Harrison BL; Janowick DA; Matthews D; McCloskey TC; Meikrantz S; Nyce PL; Vaz R; Metz WA
    J Med Chem; 2005 Feb; 48(4):995-1018. PubMed ID: 15715469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex.
    Lanza M; Bonnafous C; Colombo S; Revel L; Makovec F
    Neuropharmacology; 1997 Aug; 36(8):1057-64. PubMed ID: 9294970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of indole-2-carboxylate derivatives as antagonists of N-methyl-D-aspartate receptor activity at the associated glycine recognition site.
    Hood WF; Gray NM; Dappen MS; Watson GB; Compton RP; Cordi AA; Lanthorn TH; Monahan JB
    J Pharmacol Exp Ther; 1992 Aug; 262(2):654-60. PubMed ID: 1386886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Hydroxy-6-oxo-6,7-dihydro-thieno[2,3-b] pyrimidine derivatives: synthesis and their biological evaluation for the glycine site acting on the N-methyl-D-aspartate (NMDA) receptor.
    Hwang KJ; Lee TS; Kim KW; Kim BT; Lee CM; Park EY; Woo RS
    Arch Pharm Res; 2001 Aug; 24(4):270-5. PubMed ID: 11534755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.
    Arnt J; Sánchez C; Lenz SM; Madsen U; Krogsgaard-Larsen P
    Eur J Pharmacol; 1995 Oct; 285(3):289-97. PubMed ID: 8575516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New synthesis of substituted 2-carboxyindole derivatives: versatile introduction of a carbamoylethynyl moiety at the C-3 position.
    Hewkin CT; Di Fabio R; Conti N; Cugola A; Gastaldi P; Micheli F; Quaglia AM
    Arch Pharm (Weinheim); 1999 Feb; 332(2):55-8. PubMed ID: 10191715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indole-2-carboxylates, novel antagonists of the N-methyl-D-aspartate (NMDA)-associated glycine recognition sites: in vivo characterization.
    Rao TS; Gray NM; Dappen MS; Cler JA; Mick SJ; Emmett MR; Iyengar S; Monahan JB; Cordi AA; Wood PL
    Neuropharmacology; 1993 Feb; 32(2):139-47. PubMed ID: 8383813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
    Witkin JM; Gasior M; Heifets B; Tortella FC
    J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tricyclic indole-2-carboxylic acids: highly in vivo active and selective antagonists for the glycine binding site of the NMDA receptor.
    Katayama S; Ae N; Kodo T; Masumoto S; Hourai S; Tamamura C; Tanaka H; Nagata R
    J Med Chem; 2003 Feb; 46(5):691-701. PubMed ID: 12593650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and activity studies on glycine receptor ligands. Part 5. Diphenyl imidazolin-4-one glycinamides.
    Kieć-Kononowicz K; Karolak-Wojciechowska J
    Acta Pol Pharm; 1998; 55(5):389-96. PubMed ID: 9921117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and of their constrained analogue imidazo.
    Varano F; Catarzi D; Colotta V; Cecchi L; Filacchioni G; Galli A; Costagli C
    Eur J Med Chem; 2001 Feb; 36(2):203-9. PubMed ID: 11311751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.
    Pisani A; Gubellini P; Bonsi P; Conquet F; Picconi B; Centonze D; Bernardi G; Calabresi P
    Neuroscience; 2001; 106(3):579-87. PubMed ID: 11591458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the N-methyl-D-aspartic acid receptor associated glycine binding site.
    Salituro FG; Harrison BL; Baron BM; Nyce PL; Stewart KT; Kehne JH; White HS; McDonald IA
    J Med Chem; 1992 May; 35(10):1791-9. PubMed ID: 1534125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity.
    Jimonet P; Ribeill Y; Bohme GA; Boireau A; Chevé M; Damour D; Doble A; Genevois-Borella A; Herman F; Imperato A; Le Guern S; Manfré F; Pratt J; Randle JC; Stutzmann JM; Mignani S
    J Med Chem; 2000 Jun; 43(12):2371-81. PubMed ID: 10882363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
    Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
    Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.